about
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementin...
Read More616.8K XNAS Volume
XNAS 04 Jun, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for Metsera Inc. took place on 04 Jun 2025, for the purpose of Metsera Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Metsera Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..